文献速递病毒性肝炎

干扰素诱导巨噬细胞外泌体经miR-574-5p介导抗乙肝病毒活性

Interferon-Induced Macrophage-Derived Exosomes Mediate Antiviral Activity Against Hepatitis B Virus Through miR-574-5p.
PubMed 文献 · J Infect Dis · 2021-01-01

研究探讨聚乙二醇干扰素α(PegIFN-α)治疗慢性乙肝患者的外泌体抗病毒机制。发现应答者外泌体及IFN-α处理巨噬细胞上清可抑制HBsAg、HBeAg、HBV DNA和cccDNA。PegIFN-α上调外泌体hsa-miR-193a-5p、hsa-miR-25-5p和hsa-miR-574-5p,其中miR-574-5p通过结合HBV基因组2750-2757位点降低前基因组RNA和聚合酶mRNA。

要点

  • PegIFN-α应答者外泌体及IFN-α处理巨噬细胞上清具有抗HBV活性。
  • PegIFN-α上调外泌体miR-193a-5p、miR-25-5p和miR-574-5p。
  • miR-574-5p结合HBV基因组2750-2757位点抑制病毒复制转录。

核心结论

  • 外泌体可将IFN-α相关miRNA从巨噬细胞转移至HBV感染肝细胞,发挥抗HBV复制和表达活性。

研究设计与样本

  • 比较PegIFN-α应答者与非应答者外泌体及IFN-α处理THP-1来源巨噬细胞上清的抗HBV活性。
  • 采用miRNA测序分析外泌体miRNA表达谱,荧光素酶报告基因定位miRNA靶向的HBV基因组结合位点。

主要发现

  • PegIFN-α治疗患者外泌体(尤其应答者)及IFN-α处理巨噬细胞上清抑制HBV相关细胞系中HBsAg、HBeAg、HBV DNA和cccDNA水平。
  • PegIFN-α上调外泌体hsa-miR-193a-5p、hsa-miR-25-5p和hsa-miR-574-5p,可部分抑制HBV复制和转录。
  • hsa-miR-574-5p通过结合HBV基因组序列2750-2757位点降低前基因组RNA和聚合酶信使RNA水平。

临床怎么用

  • 提示外泌体miRNA(尤其miR-574-5p)可能作为PegIFN-α抗HBV疗效的机制标志或增强策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Interferon alfa (IFN-α) has been proved effective in treating chronic hepatitis B (CHB), owing to its ability to suppress hepatitis B surface antigen and hepatitis B virus (HBV) covalently closed circular DNA. However, the underlying mechanisms are unclear. METHODS: We investigated the antiviral activities of exosomes from responders and nonresponders to pegylated IFN-α (PegIFN-α) as well as the supernatants of IFN-α-treated macrophages derived from THP-1 (the human leukemia monocyte cell line). Then the expression profiles of exosomal microRNAs (miRNAs) were analyzed using miRNA sequencing. The luciferase reporter assay was used to locate the binding position of HBV genomic sequence targeted by the identified miRNA. RESULTS: Exosomes from PegIFN-α-treated patients, particularly responders, as well as the supernatants of IFN-α-treated macrophages exhibited anti-HBV activities, as manifested by the suppression of hepatitis B surface antigen, hepatitis B e antigen, HBV DNA, and covalently closed circular DNA levels in HBV-related cell lines. PegIFN-α treatment up-regulated exosomal hsa-miR-193a-5p, hsa-miR-25-5p, and hsa-miR-574-5p, which could partially inhibit HBV replication and transcription, and hsa-miR-574-5p reduced pregenomic RNA and polymerase messenger RNA levels by binding to the 2750-2757 position of the HBV genomic sequence. CONCLUSIONS: Exosomes can transfer IFN-α-related miRNAs from macrophages to HBV-infected hepatocytes, and they exhibit antiviral activities against HBV replication and expression.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Wu W, Wu D, Yan W, et al. Interferon-Induced Macrophage-Derived Exosomes Mediate Antiviral Activity Against Hepatitis B Virus Through miR-574-5p. J Infect Dis. 2021. PMID: 32663850. doi:10.1093/infdis/jiaa399

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。